These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18057825)

  • 1. Prognostic significance of surgical margin, Ki-67 and cyclin D1 protein expression in grade II canine cutaneous mast cell tumor.
    Ozaki K; Yamagami T; Nomura K; Narama I
    J Vet Med Sci; 2007 Nov; 69(11):1117-21. PubMed ID: 18057825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994-2002).
    Séguin B; Besancon MF; McCallan JL; Dewe LL; Tenwolde MC; Wong EK; Kent MS
    J Vet Intern Med; 2006; 20(4):933-40. PubMed ID: 16955819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanog Expression and Proliferation Indices in Canine Cutaneous Mast Cell Tumors.
    Joselevitch JA; Barra CN; Vargas THM; Pulz LH; Nishiya AT; Kleeb SR; Xavier JG; Catão-Dias JL; Strefezzi RF
    Vet Pathol; 2018 Nov; 55(6):849-852. PubMed ID: 30025495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional local therapy with primary re-excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs.
    Kry KL; Boston SE
    Vet Surg; 2014 Feb; 43(2):182-9. PubMed ID: 24392683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogs.
    Fonseca-Alves CE; Bento DD; Torres-Neto R; Werner J; Kitchell B; Laufer-Amorim R
    Res Vet Sci; 2015 Oct; 102():122-6. PubMed ID: 26412531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of dogs undergoing surgical resection of mast cell tumors and soft tissue sarcomas: A prospective 2-year-long study.
    Milovancev M; Townsend KL; Tuohy JL; Gorman E; Bracha S; Curran KM; Russell DS
    Vet Surg; 2020 Jan; 49(1):96-105. PubMed ID: 31044443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.
    Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F
    Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 immunohistochemical expression and somatic mutations in canine oral melanoma.
    Zamboni C; Brocca G; Ferraresso S; Ferro S; Sammarco A; Dal Corso C; Iussich S; de Andres PJ; Martìnez de Merlo EM; Cavicchioli L; Zappulli V; Castagnaro M
    Vet Comp Oncol; 2020 Jun; 18(2):231-238. PubMed ID: 31503380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductions in margin length after excision of grade II mast cell tumors and grade I and II soft tissue sarcomas in dogs.
    Milovancev M; Townsend KL; Bracha S; Gorman E; Curran K; Russell DS
    Vet Surg; 2018 Jan; 47(1):36-43. PubMed ID: 29064583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence.
    Sawair F; Hassona Y; Irwin C; Stephenson M; Hamilton P; Maxwell P; Gordon D; Leonard A; Napier S
    Asian Pac J Cancer Prev; 2016; 17(3):1243-9. PubMed ID: 27039754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine subcutaneous mast cell tumor: characterization and prognostic indices.
    Thompson JJ; Pearl DL; Yager JA; Best SJ; Coomber BL; Foster RA
    Vet Pathol; 2011 Jan; 48(1):156-68. PubMed ID: 21078881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy.
    Aaltomaa S; Kärjä V; Lipponen P; Isotalo T; Kankkunen JP; Talja M; Mokka R
    Anticancer Res; 2006; 26(6C):4873-8. PubMed ID: 17214354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
    Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
    J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
    Ortiz AB; Garcia D; Vicente Y; Palka M; Bellas C; Martin P
    PLoS One; 2017; 12(11):e0188068. PubMed ID: 29140993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
    Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
    Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
    Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.